Shots:
PharmaShots speaks with Thomas Chalberg, Founder and CEO of Genascence Corporation, and Annahita Keravala, Founder and CSO of Genascence Corporation
Thomas and Annahita speak eloquently about Genascence's current lead program, GNSC-001, for osteoarthritis of the knee, and shed light on the unmet medical needs in the disease
The duo highlighted the safety and tolerability…
In an endless pursuit of excellence, PharmaShots celebrates its 7th anniversary today. Thanks to the unflinching support of our readers and clients, we have no doubt continued to push ourselves towards new horizons
We made a humble start as a news-delivering platform and gradually evolved with services that cater to the unmet marketing and branding…
Regenerative medicine holds a promising potential in addressing unmet medical needs and bridging the gaps in healthcare. Regenerative medicine aims to provide innovative ways to repair, rejuvenate, and replace damaged tissues and organs. Regenerative medicine is widely explored in clinical settings as cellular therapies, extracellular vesicle therapies, immune cellular therapies, and tissue-engineered grafts to prevent…
Decentralized Clinical Trials (DCTs) colloquially known as hybrid trials were popularized during COVID-19. With the changing healthcare landscape, trial sponsors are looking for practices that are feasible and cost-effective. DCTs offer holistic solutions to mitigate the gaps in traditional clinical trial models by integrating emerging technologies and gadgets into the nuanced aspects of data capturing.…
Shots:
In this episode of the CXO Talks podcast, PharmaShots spoke with Tim O’Connell, CEO of Emtelligent, a next-generation medical AI company
Tim highlights Emtelligent’s inspiring journey to becoming a leader in a clinical-grade NLP company focused on transforming unstructured data to actionable insights at an enterprise scale
Emtelligent leverages the power of medical records…
In the CXO Talks podcast, PharmaShots engaged in a riveting dialogue exchange with Colin Banas, Chief Medical Officer at DrFirst. Colin highlights the evolution of DrFirst from becoming a leader in the e-prescribing space to an end-to-end medication management company
Colin talks about its collaborators, Wise Hospice Options, achieving a new milestone by reducing the…
Automation remained a quintessential force throughout 2024 in shaping the biopharma industry. 2025 on the other hand is experiencing advanced applications of automated tools and enablers in different aspects of drugs life cycles. PharmaShots through this magazine navigates automated packaging by decrypting the complexities of automation.
The magazine unfolds the role of automation in biopharma…
Shots:
Precision Medicine is a rapidly evolving field offering targeted treatments for optimal patient care
Education around testing is a critical need as many barriers exist that create practice gaps to patient identification
Testing State Awareness (TSA) is a critical component that needs to complement Brand and Disease State Awareness campaigns
Anton Yarovoy, Group Product…
In the CXO Talks podcast, PharmaShots spoke with Ali Jannati, Director of Cognitive Science at Linus Health. Ali eloquently highlighted Linus’ journey to becoming a leader in digital brain health through its innovative digital cognitive assessment platform
He emphasized the importance of digital biomarkers in evaluating brain function by capturing subtle nuances and response latencies,…
Emerging technologies holds a promising foothold in redefining the aspects of preventative, diagnostic, therapeutic, and patient care in the healthcare landscape. 3D Bioprinting offers innovative approach to addressing unmet healthcare needs with efficacious precision medicine in life-threatening conditions and developing therapies and medical devices that mimic complex human physiology.
In April, PharmaShots Magazine is exploring…

